ArticleCurrent oncology (Toronto, Ont.)2019
Cost-effectiveness analysis of selective first-line use of biologics for unresectable
W W L Wong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it